Skip to content

Author

Ying-Ying Hu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Targeting the cardiohepatic-metabolic axis: GLP-1-based and incretin multi-agonist therapies in MASH.

Metabolic dysfunction-associated steatohepatitis (MASH) has emerged as a leading cause of chronic liver disease worldwide and is increasingly recognized as a systemic metabolic-inflammatory disorder closely linked to cardiovascular risk. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and emerging incretin-based m...

Yi-Wen Zhang, Ying-Ying Hu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.